ADBiotech Co

ADBiotech Co EBIT Growth

The Year-over-Year EBIT Growth of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is 60.27 %. In the previous year, Year-over-Year EBIT Growth was -19.34 % — a change of -411.70% (higher).

EBIT Growth

60.27 %

YoY

-411.70%

Last updated:

Year-over-Year EBIT Growth of ADBiotech Co is 2025 60.27 % . Year-over-Year EBIT Growth of ADBiotech Co was 2024 -19.34 % . It decreases by -411.70% higher compared to the previous year.

The ADBiotech Co EBIT Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Growth
Date
EBIT Growth
Jan 1, 2018
-1,292.08 KRW
Jan 1, 2019
107.79 KRW
Jan 1, 2020
-491.10 KRW
Jan 1, 2021
-129.89 KRW
Jan 1, 2022
-115.63 KRW
Jan 1, 2023
-49.53 KRW
Jan 1, 2024
-19.34 KRW
Jan 1, 2025
60.27 KRW
The ADBiotech Co EBIT Growth history
YEAREBIT GrowthYoY
60.27 %-411.70%
-19.34 %-60.96%
-49.53 %-57.16%
-115.63 %-10.98%
-129.89 %-73.55%
-491.10 %-555.60%
107.79 %-108.34%
-1,292.08 %-1,167.71%
121.01 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Year-over-Year EBIT Growth of ADBiotech Co is 60.27 % in 2025.

On Eulerpool you can find the complete historical development of Year-over-Year EBIT Growth ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

EBIT growth measures the percentage change in operating earnings. It shows whether a company's core operations are becoming more profitable.

To evaluate Year-over-Year EBIT Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBIT Growth.

Year-over-Year EBIT Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBIT Growth's ADBiotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — ADBiotech Co

All Key Metrics — ADBiotech Co